Clinical Trials Browser

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04771130 2026-03-04

A Study of BGB-11417 in Participants With Myeloid Malignancies

Phase 1/2 Recruiting

260 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT06802757 2026-02-25

PRISM-TNBC

Phase 2 Recruiting

72 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06541067 2026-01-26

POSALLO

Phase 2 Recruiting

30 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04825275 2026-01-23

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Phase EARLY_PHASE1 Terminated

7 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03828773 2025-12-09

PTX3AML

Phase NA Recruiting

410 enrolled

Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

NCT03763396 2024-03-08

Azoles Targeting Recurrent High Grade Gliomas

Phase EARLY_PHASE1 Not yet recruiting

30 enrolled

CNS

Brain Neoplasms, Glioma, Neoplasms

NCT02203773 2023-05-16

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Phase 1 Terminated

212 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03796533 2022-02-24

Posa-Pk

Phase NA Unknown

120 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Phase 1 Completed

31 enrolled

Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

NCT02875743 2020-04-02

King's Invasive Aspergillosis Study II

Phase 4 Completed

120 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT03036046 2018-02-15

SAFEGUARDFP

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Clinical Trials

MOMENTUM

A Study of BGB-11417 in Participants With Myeloid Malignancies

PRISM-TNBC

POSALLO

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

PTX3AML

Azoles Targeting Recurrent High Grade Gliomas

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Posa-Pk

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

King's Invasive Aspergillosis Study II

HDM201 Added to CT in R/R or Newly Diagnosed AML

SAFEGUARDFP

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)